Advanced Critical Care Nursing Symposium Day 1-Management of the Complex Cardiac Patient – Dr. Paul Langlois

Salepage link: At HERE. Archive:

Take your practice to the next level with cutting-edge strategies for the most challenging & complex patients

Working in the rapidly changing critical care setting, you need to be, up to date on the most current and cutting-edge strategies and interventions to care for these high acuity patients. Get the latest and greatest in this exciting and engaging conference, where expert, Dr. Paul Langlois, APN, PhD, CCRN, CCNS, CNRN, will challenge you to take your knowledge to the next level. He will discuss the most common, yet most challenging cases, that critical care nurses are working with each day:

• Heart Failure
• STEMI & NSTEMI
• Pneumonia
• ARDS
• Ischemic & Hemorrhagic Stroke
• Renal Failure
• Multi-system Failure

Attend this comprehensive program and leave with practical, immediately applicable strategies to gain better patient outcomes and enhance your expertise. Don’t miss this opportunity to network with your peers, learn from an expert in the field, and leave with a renewed commitment to achieving excellence in critical care nursing.

OUTLINE

Case Study: The patient with Heart Failure (HF)

• Preserved Ejection Fraction vs. Reduced Ejection Fraction
  • Physical Assessment Findings
  • How to Appropriately Classify HF
  • Labs to Aid in Diagnosis
• Medications for Heart Failure
  • Four Classes of Diuretics
  • Three Inotropic Agents
    • Minimizing HF Symptoms
  • Angiotensin Converting Enzyme Inhibitor
  • Aldosterone Receptor Antagonists
• Echocardiogram Interpretation
• Electronic Support of the Heart
  • AICD, Biventricular Pacing
  • Three Trouble Shooting Techniques
• Decompensating HF Treatment
  • Ventricular Assist Devices (VAD)
    • Five Indications & Contraindications
    • Six Trouble Shooting Techniques
  • Driveline Infections
    • Recognition & Treatment

Case Study: STEMI and NSTEMI

• Diagnosis: STEMI vs. NSTEMI
  • Lab Data: Troponins and CK-MB
  • Patient Signs & Symptoms
• 12-Lead Interpretation
  • Inferior, Lateral & Anterior Wall MI
  • How to Identify Axis Deviation
  • Differentiating Left from Right Bundle Branch Block
  • Recognizing Bifacicular Blocks after MI
• Medication Management
  • Beyond Aspirin, Oxygen, Nitroglycerine & Morphine
  • Indications for Using TPA
  • Three Factors to Consider when Dosing Heparinoids
  • Glycoprotein IIb/IIIa Medications for STEMI
  • Intravenous Direct Thrombin Inhibitors
    • Monitoring Parameters
• Thienopyridines
  • When to Administer
• Four Indications for:
  • Angiotension Converting Enzyme Inhibitors
  • Angiotension Receptor Blocking Agents
  • Indications for Statins
  • Three Indications for Vitamin K Receptor Antagonists
  • Stop the NSAIDS
• Percutaneous Interventions
  • Drug-eluting vs. Bare Metal Stents
  • Balloon Angioplasty
• Coronary Artery Bypass Surgery is NOT for Everyone
• Cardiogenic Shock after MI
  • Pulmonary Artery Catheter with Venous Waveform Analysis
  • Cardiac Output Determination by Pulse Contour Methods
  • Extracorporeal Membrane Oxygenation (ECMO)
    • Indications & Contraindications
    • What do the Numbers Mean?

OBJECTIVES

1. Investigate current clinical guidelines and management strategies for heart failure.
2. Review important pharmacologic principles essential for safe and effective care.
3. Assess the most prevalent inotropic agents used in the management of heart failure.
4. Describe the mechanisms of action of mortality-reducing pharmacological agents used in the treatment of MI and HF.
5. Compare anticoagulants which are most beneficial to the patient with MI.
6. Compare physical assessment findings to hemodynamic parameters in a patient with decompensated heart failure.
7. Review potentially fatal arrhythmias found on the EKG.